LONDON, March 10, 2005 (PRIMEZONE) -- Antisoma plc (LSE: ASM) today announces that Chief Executive Officer, Glyn Edwards, will be presenting at the 25th SG Cowen Annual Healthcare conference, Boston, Mass., USA.
Mr Edwards's presentation is scheduled for 10.30am EST on Thursday, March 17, with an additional breakout session at 11.20am. A webcast of the presentation will be available to all on Antisoma's website at www.antisoma.com
It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live web cast, a recorded replay of the presentation will be available for 90 days.
Enquiries:
Margherita Lupi +44 (0)20 8799 8200 Corporate Communications Manager Antisoma plc
Background on Antisoma:
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. In November 2002, Antisoma formed a broad strategic alliance with Roche to develop and commercialise products from Antisoma's pipeline. Please visit www.antisoma.com for further information.
-0-